The public is bombarded with news of exciting developments in cancer research every day, with new anti-cancer drugs greeted with excitement. But what happens to these drugs? When do they become accessible to cancer patients – if at all?
The public is bombarded with news of exciting developments in cancer research every day, with new anti-cancer drugs greeted with excitement. But what happens to these drugs? When do they become accessible to cancer patients – if at all?